Substance – Talk Bio

Medidata, Oncology Trials, Vaccine Trials, Bundled Solutions, Clinical Trial Efficiency, Patient-Centered Endpoints, Adaptive Trial Designs, Trial Diversity

Mitigating Risks in mRNA Manufacturing: Strategies for Smooth Transition from Preclinical to Clinical Stages

1 year ago talkbio0Tagged analytical method, Automation, bony process, clinical transition, Control Groups, Materials, Preclinical, Quality, regulatory, Risk Management, RNA, Messenger

mRNA manufacturing, risk management, preclinical to clinical transition, quality control, regulatory compliance, raw material selection, process automation, analytical methods.

B. Braun’s Florida IV Fluid Plant Resumes Operations After Minimal Damage from Hurricane Milton

1 year ago talkbio0Tagged B. Braun, Florida Facility, Hurricanes, Liquid substance, Milton

B. Braun, Hurricane Milton, IV Fluids, Florida Facility, Supply Chain

HPV-Based Cervical Cancer Screening: Insights into Sample Preference and Cost-Effectiveness

1 year ago talkbio0Tagged Cost Effectiveness, Human papilloma virus screening, Malignant tumor of cervix, preference, Screening guidelines, Specimen

HPV testing, Cervical cancer screening, Sample preference, Cost-effectiveness, Screening guidelines

WHO Publishes First Guidance to Combat Antibiotic Pollution from Manufacturing

1 year ago talkbio0Tagged Administration occupational activities, AMR, antibiotic pollution, Antimicrobial Resistance, Environmental Health, Microbicides, pharmaceutical manufacturing, solid waste management, Wastewater, World Health Organization

WHO, antibiotic pollution, antimicrobial resistance (AMR), wastewater management, solid waste management, pharmaceutical manufacturing, environmental health

Takeda Announces 641 Layoffs in Massachusetts Amid $900 Million Restructuring Campaign

2 years ago talkbio0Tagged Cambridge, Lexington, Massachusetts (geographic location), restructuring, Takeda

Takeda, layoffs, Massachusetts, restructuring, pharmaceuticals, biotech, Cambridge, Lexington